ArticleCancer management and research2021

Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment.

Jingtao Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.